Stoke Therapeutics STOK - Options Chain | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Stoke Therapeutics Inc (STOK)
Stoke Therapeutics Inc (STOK) Options

Stoke Therapeutics Inc (STOK)

10.62

0.02

(0.19%)

Closed 26 January 8:00AM

Delayed by 15 minutes

10.62

0.01

(0.09%)

After Hours: 10:37AM

Delayed by 15 minutes

STOK Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	6.00	10.50	11.70	8.25	0.00	0.00 %	0	1	-
5.00	5.10	6.70	5.40	5.90	0.00	0.00 %	0	1,953	-
7.50	2.55	4.20	2.50	3.375	0.00	0.00 %	0	532	-
10.00	1.00	1.75	1.28	1.375	0.00	0.00 %	0	894	-
12.50	0.15	2.20	0.40	1.175	0.00	0.00 %	0	862	-
15.00	0.20	1.50	0.20	0.85	0.00	0.00 %	0	12	-
17.50	0.05	4.90	0.05	2.475	0.00	0.00 %	0	4	-
20.00	0.35	0.75	0.35	0.55	0.00	0.00 %	0	1	-
22.50	0.21	0.75	0.21	0.48	0.00	0.00 %	0	3	-
25.00	0.35	0.75	0.35	0.55	0.00	0.00 %	0	1	-

Professional-Grade Tools, for Individual Investors.

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	0.00	0.75	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.05	1.25	0.05	0.65	0.00	0.00 %	0	110	-
7.50	0.15	0.70	0.15	0.425	0.00	0.00 %	0	163	-
10.00	0.65	0.85	0.75	0.75	-0.15	-16.67 %	1	134	25/1/2025
12.50	1.70	5.00	4.30	3.35	0.00	0.00 %	0	61	-
15.00	2.50	7.00	3.75	4.75	0.00	0.00 %	0	66	-
17.50	4.70	9.00	0.00	6.85	0.00	0.00 %	0	0	-
20.00	7.40	11.50	0.00	9.45	0.00	0.00 %	0	0	-
22.50	10.70	14.00	0.00	12.35	0.00	0.00 %	0	0	-
25.00	13.20	16.50	0.00	14.85	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NVNINVNI Group Ltd	US$ 4.38 (193.96%)	366.98M
EVAXEvaxion Biotech AS	US$ 5.99 (64.56%)	55.41M
ELABPMGC Holdings Inc	US$ 3.0901 (56.07%)	76.48M
PCLAPicoCELA Inc	US$ 4.60 (49.35%)	3.75M
GOEVCanoo Inc	US$ 0.475 (43.94%)	282.22M
GODNUGolden Star Acquisition Corporation	US$ 3.11 (-75.82%)	17.51k
GODNGolden Star Acquisition Corporation	US$ 2.93 (-65.67%)	902.76k
NXTTNext Technology Holding Inc	US$ 1.37 (-54.93%)	2.56M
SGLYSingularity Future Technology Ltd	US$ 1.625 (-38.45%)	917.77k
WHLRLWheeler Real Estate Investment Trust Inc	US$ 90.11 (-38.07%)	8
ACONAclarion Inc	US$ 0.0557 (28.94%)	811.91M
NVNINVNI Group Ltd	US$ 4.38 (193.96%)	366.98M
RIMEAlgorhythm Holdings Inc	US$ 0.0357 (4.69%)	284.97M
GOEVCanoo Inc	US$ 0.475 (43.94%)	282.22M
NVDANVIDIA Corporation	US$ 142.62 (-3.12%)	232.88M

PonkenPlonken

PonkenPlonken 2 months ago

I am so STOKED about this company. They were doing this before they all figured out you need RNA science for gene therapy.
See SRPT ARWR deal! another AAV based gene tx seeking RNAI

Monksdream

Monksdream 5 months ago

Zardiw

Zardiw 10 months ago

$STOK Chart from #DDAmanda - #1 Stock Screener :

Scans are preset. Push a Button. Find Winners Early:

Z

TimeFades

TimeFades 10 months ago

Choppy day shoulda just stuck with my morning short

TimeFades

TimeFades 10 months ago

Got bullish again and covered

TimeFades

TimeFades 10 months ago

Invest-in-America

Invest-in-America 10 months ago

STOK: "Stoke Therapeutics (NASDAQ:STOK) stock shot up 70% in post-market trading Monday after the company reported positive results from studies for its drug STK-001 in the treatment of children and adolescents with Dravet syndrome, a genetic form of epilepsy. The biotech company said data from two Phase 1/2a studies and two open label extension, or OLE, studies showed “clinically meaningful effects” that included “substantial and durable reductions in convulsive seizure frequency."
https://seekingalpha.com/news/4083468-stoke-stock-soars-post-market-on-epilepsy-drug-data

Dravet Syndrome is an extremely RARE disease in the USA. And the above news does NOT specify nor suggest that STOK's (potential) treatment for Dravet Syndrome will or might have any applications for treatment of EPILEPSY at all. (Be very CAREFUL about news like the above.)

Stoke Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions